THE WHAT? Revlon has entered into an Amendment No.9 to its 2016 Asset-Based Revolving Credit Agreement in order to temporarily increase the borrowing base by up to US$25 million until September 29, this year.
THE DETAILS During the Amendment No. 9 accommodation period, the new provision also establishes a reserve against availability under the 2016 revolving credit agreement in the amount of US$10 million until June 29, 2022 and US$15 million thereafter.
THE WHY? Revlon may seek to raise capital this year and filed a registration statement with the SEC on March 31 to sell up to US$75 million of debt, equity and other securities, with the net proceeds used to manage and help alleviate the supply chain disruptions that have been previously disclosed by the company and have impacted Revlon’s ability to meet customer demand for its products.
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
